Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
SMS Pharmaceuticals's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 18.81%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for SMS Pharmaceuticals's 3-Year ROIIC % or its related term are showing as below:
BOM:532815's 3-Year ROIIC % is ranked better than 69.99% of 943
companies
in the Drug Manufacturers industry
Industry Median: 3.56
vs BOM:532815: 18.81
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
SMS Pharmaceuticals 3-Year ROIIC % Related Terms
SMS Pharmaceuticals 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for SMS Pharmaceuticals's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:532815 vs LLY, JNJ, ABBV: 3-Year ROIIC % Comparison
For the Drug Manufacturers - General subindustry, SMS Pharmaceuticals's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SMS Pharmaceuticals 3-Year ROIIC % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, SMS Pharmaceuticals's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where SMS Pharmaceuticals's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
SMS Pharmaceuticals (BOM:532815) has a 3-Year ROIIC % of 18.81 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on SMS Pharmaceuticals and its competitors. According to the industry distribution chart, SMS Pharmaceuticals ranks #283 out of 943 companies in the Drug Manufacturers industry, placing it in the top 30%.
Is SMS Pharmaceuticals' 3-Year ROIIC % too high?
SMS Pharmaceuticals' current 3-Year ROIIC % is 18.81. The Drug Manufacturers industry median 3-Year ROIIC % is 3.56. SMS Pharmaceuticals' value of 18.81 is 428.4% above this industry median. Based on the distribution chart, SMS Pharmaceuticals ranks #283 out of 943 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, SMS Pharmaceuticals has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SMS Pharmaceuticals' 3-Year ROIIC % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, SMS Pharmaceuticals ranks #283 out of 943 companies for 3-Year ROIIC %. This puts SMS Pharmaceuticals in the upper half of its industry. The industry median 3-Year ROIIC % is 3.56. SMS Pharmaceuticals' value of 18.81 is 428.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Drug Manufacturers company?
The median 3-Year ROIIC % among Drug Manufacturers companies is 3.56, based on 943 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SMS Pharmaceuticals's current 3-Year ROIIC % of 18.81 is 428.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on SMS Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median 3-Year ROIIC % is 3.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SMS Pharmaceuticals's current 3-Year ROIIC % is 18.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMS Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, SMS Pharmaceuticals (BOM:532815) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹282.72, compared to a current price of ₹356.60 — trading 26.1% above its estimated fair value. The current 3-Year ROIIC % is 18.81 and 428.4% above the Drug Manufacturers industry median of 3.56. SMS Pharmaceuticals' overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For SMS Pharmaceuticals (BOM:532815), the current 3-Year ROIIC % is 18.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMS Pharmaceuticals (BOM:532815) Overvalued in 2026?
Based on GuruFocus' analysis, SMS Pharmaceuticals stock appears to be overvalued.
The current stock price of ₹356.60 is trading 26.1% above its estimated GF Value™ of ₹282.72.
GuruFocus considers SMS Pharmaceuticals to be Modestly Overvalued.
Key valuation signals for BOM:532815:
3-Year ROIIC %: 18.81
GF Value™: ₹282.72 vs. price of ₹356.60 (26.1% above fair value)
Industry Position: 428.4% above the Drug Manufacturers median (#283 of 943)
No single metric tells the full story. See the BOM:532815 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SMS Pharmaceuticals Ltd is a drug manufacturing company. It is engaged in the business of manufacturing Active Pharma Ingredients and their intermediates. Its product portfolio includes drugs for anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, anti-viral, and other conditions.
78GF Score
Get the complete analysis for BOM:532815
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532815 has been successfully added to your 
